Real-time enrollment status for this alzheimer's disease clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 9:32 PM UTC
| NCT Number | NCT06585787 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer's Disease |
| Phase | PHASE3 |
| Target Enrollment | 406 participants |
| Active Locations | 99 sites in the US |
| Sponsor | Karuna Therapeutics |
| Last Updated on CT.gov | July 7, 2026 (1 week ago) |
As of July 16, 2026: Clinical trial NCT06585787 is currently recruiting participants. This phase3 study for alzheimer's disease is actively seeking new participants at 99 locations across the United States. The study is sponsored by Karuna Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06585787 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 99 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06585787 was last updated 1 week ago (July 7, 2026). HelloStudys verifies this status automatically.